Covalent Laboratories Private Limited Company Profile

01:47 EDT 1st August 2015 | BioPortfolio

Covalent Laboratories Private Limited, an ISO 9001:2000 accredited pharmaceutical company and WHO GMP certified for all its products, is specialized in the manufacturing of Cephalosporins. It has a wide range of products and is fast expanding to meet the present and future market demands for the high value, low volume drugs. Covalent Laboratories manufactures the Active Pharmaceutical Ingredient (API) in bulk quantities for both domestic and international markets. All the drugs manufactured meets USP/BP/JP standards

Location

Flat No. 109, 1st Floor, Ram's Enclave, Erragadda
Hyderabad
Andhra Pradesh
18
India

Contact

Phone: 91-40-23818102/03
Fax: 91-40-23815967
Email: enquiry@covalentlab.com


News Articles [467 Associated News Articles listed on BioPortfolio]

Erratum: Covalent docking of large libraries for the discovery of chemical probes

Prolonged and tunable residence time using reversible covalent kinase inhibitors

Coronado Biosciences Announces Exclusive Licensing Agreement With NeuPharma to Develop and Commercialize Novel Covalent 3rd Generation EGFR Inhibitors

NEW YORK, March 19, 2015 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO) announced today the execution of an exclusive license agreement with NeuPharma, Inc. to develop and commercialize...

Principia Biopharma and UCSF Scientists Announce Publication of Seminal Paper on Reversible Covalent Drugs in Nature Chemical Biology

Principia Biopharma Inc., a private, clinical-stage biopharmaceutical company, today announced the publication of a seminal paper establishing a new category of oral small molecul...

Mylan Laboratories Limited (formerly Matrix Laboratories Limited) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Recently added to the BioPortfolio report store, Mylan Laboratories Limited (formerly Matrix Laboratories Limited) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ...

Disparity in Funding and Research Efforts between Feds and Private Industry Limiting Research in Regenerative Medicine, According to BCC Research

Wellesley, MA (PRWEB) June 15, 2015 Regenerative medicine receives more than 10 times as much private funding as government funding. While private-industry research typically focuses on developing ...

Stiefel Laboratories, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Recently added to the BioPortfolio report store, Stiefel Laboratories, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report is a new report from MarketLine ...

Charles River Laboratories hunts for M&A

M&A hunt: Speaking at the Leerink Swann Global Healthcare Conference last week, James Foster, chief executive officer of Charles River Laboratories, indicated the company was actively looking for ...

PubMed Articles [577 Associated PubMed Articles listed on BioPortfolio]

The Quality of Sputum Smear Microscopy in Public-Private Mix Directly Observed Treatment Laboratories in West Amhara Region, Ethiopia.

Ethiopia adopted Public-Private Mix Directly Observed Treatment Short Course Chemotherapy (PPM-DOTS) strategy for tuberculosis (TB) control program. Quality of sputum smear microscopy has paramount im...

Preparing for Ebolavirus disease: specimen collection, packaging and transport.

Ebolavirus is classified by Standards Australia as a Risk Group 4 pathogen for handling in laboratories. Specimens known or reasonably expected to contain Ebolavirus are classified by the United Natio...

International Survey on D-Dimer Test Reporting: A Call for Standardization.

D-dimer is the biochemical gold standard for diagnosing a variety of thrombotic disorders, but result reporting is heterogeneous in clinical laboratories. A specific five-item questionnaire was develo...

ACO contracting with private and public payers: a baseline comparative analysis.

Objectives The accountable care organization (ACO) model is currently being pursued by private insurers, as well as federal and state governments. Little is known, however, about the prevalence of pri...

General practitioners' altered preferences for private practice vs. salaried positions: a consequence of proposed policy regulations?

General practitioners (GPs) in most high-income countries have a history of being independent private providers with much autonomy. While GPs remain private providers, their autonomous position appear...

Clinical Trials [246 Associated Clinical Trials listed on BioPortfolio]

B-Type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice

Cost-effective management of heart failure and pulmonary disease is of paramount importance. Unfortunately, the rapid and accurate differentiation of heart failure from other causes of dys...

Medical Education in a Private Hospital

The purpose of this study is to assess patient and companion acceptability of medical education in a non-teaching private hospital

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

To correlate the HLA type and genetic defect with hemophilia A.

A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin)

This one-arm, multi-centric, non-randomized, observational, open label, prospective study was designed to study short subjects born SGA, by pediatricians, endocrinologists or physicians in...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [1694 Associated Companies listed on BioPortfolio]

Covalent Laboratories Private Limited

Covalent Laboratories Private Limited, an ISO 9001:2000 accredited pharmaceutical company and WHO GMP certified for all its products, is specialized in the manufacturing of Cephalosporins. It has a wi...

Convalent group

A leader in the design, development, and management of complex clinical trials for the world's leading pharmaceutical, biotechnology, and medical device companies, Covalent Group's intellectual, hard ...

Covalent Marketing

EIC Laboratories, Inc

EIC Laboratories is a research and development corporation serving government and industrial clients worldwide. Since our inception in 1971, EIC Laboratories has been committed to converting basic res...

Covalent Group Incorporated

The Covalent Group is a unique drug development and research managment company with the ability to design complete development strategies, provide input from world-renown thought leaders, design and a...

More Information about "Covalent Laboratories Private Limited" on BioPortfolio

We have published hundreds of Covalent Laboratories Private Limited news stories on BioPortfolio along with dozens of Covalent Laboratories Private Limited Clinical Trials and PubMed Articles about Covalent Laboratories Private Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Covalent Laboratories Private Limited Companies in our database. You can also find out about relevant Covalent Laboratories Private Limited Drugs and Medications on this site too.


Advertisement
 
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record